SCHEMBL2813022

SCHEMBL2813022

Brc1c2ccccc2c(-c2cccnc2)c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.52
ALDH1A1 P00352 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP11B1 P15538 4/20 0.47
IDO1 P14902 1/20 0.46
LRRK2 Q5S007 1/20 0.46
TP53 P04637 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HSD17B10 Q99714 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
ALOX15 P16050 1/20 0.45
HTT P42858 1/20 0.45
CYP11B2 P19099 4/20 0.44
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CYP19A1 P11511 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22470317 0.91 CYP2A6 (0.52) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL13145318 0.90 CYP2A6 (0.64) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL29515584 0.90 CYP2A6 (0.64) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL19990185 0.87 CYP2A6 (0.50) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL27845488 0.86 CYP11B1 (0.50) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL24662771 0.86 CYP2A6 (0.58) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL20740877 0.83 CYP2A6 (0.67) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL1102698 0.82 CYP2A6 (0.54) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL16455820 0.82 CYP11B1 (0.53) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1
SCHEMBL13911013 0.82 CYP2A6 (0.58) CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250160203-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-05-15 US disclosed
US-12302685-B2 Light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-05-13 US disclosed
US-12295260-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-05-06 US disclosed
US-20240292648-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-08-29 US disclosed
EP-4383988-A1 ORGANIC LIGHT EMITTING DIODE, DEVICE COMPRISING THE SAME AND COMPOUND Novaled GmbH (DE) 2024-06-12 EP disclosed
CN-117964605-A Arylpyrazole pyridine derivative and preparation method and application thereof 北京工业大学 2024-05-03 CN disclosed
US-11974447-B2 Light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-04-30 US disclosed
US-20230337462-A1 LIGHT-EMITTING DEVICE, FUNCTIONAL PANEL, LIGHT-EMITTING APPARATUS, DISPLAY DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-10-19 US disclosed
US-20230337462-A1 LIGHT-EMITTING DEVICE, FUNCTIONAL PANEL, LIGHT-EMITTING APPARATUS, DISPLAY DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-10-19 US disclosed
US-20230337462-A1 LIGHT-EMITTING DEVICE, FUNCTIONAL PANEL, LIGHT-EMITTING APPARATUS, DISPLAY DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-10-19 US disclosed
US-8859108-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-14 US disclosed
US-8481176-B2 Oxadiazole derivative, and light-emitting element, light-emitting device, electronic device, and lighting device using oxadiazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-07-09 US disclosed
US-8481176-B2 Oxadiazole derivative, and light-emitting element, light-emitting device, electronic device, and lighting device using oxadiazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-07-09 US disclosed
US-8481176-B2 Oxadiazole derivative, and light-emitting element, light-emitting device, electronic device, and lighting device using oxadiazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-07-09 US disclosed
US-20100244673-A1 Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-09-30 US disclosed
US-20100244673-A1 Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-09-30 US disclosed
US-20100244673-A1 Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-09-30 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12295260-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device NQO1, CYP1A1, CYBA CYP2A6 351/4885ALDH1A1 191/4885CYP1A2 15/4885
US-20250160203-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device NQO1, CYP1A1, CYBA CYP2A6 351/4885ALDH1A1 191/4885CYP1A2 15/4885
US-20100244673-A1 Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative OXA1L, OXER1, DRD1 CYP2A6 377/4885ALDH1A1 18/4885CYP1A2 21/4885
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same CYP4X1, XDH, GABRA5 CYP2A6 345/4885ALDH1A1 169/4885CYP1A2 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.